Welcome to the Affinity Whole Health Blog

Explore expert insights, practical health tips, and the latest advancements in wellness from Affinity Whole Health. Our blog is your go-to resource for understanding Testosterone Replacement and Hormone Therapy, weight loss solutions, and personalized care, crafted by our experienced team.

Discover how our comprehensive lab testing, telehealth consultations, and dedicated Patient Care Coordinators empower you to achieve your health goals with confidence and support. Start your journey to better health today!

Testosterone Chris Lyons Testosterone Chris Lyons

Testosterone Injections: Why Twice-Weekly Dosing and Subcutaneous Administration Offer Clear Advantages

Subcutaneous testosterone injections are becoming a preferred option for men undergoing testosterone replacement therapy (TRT). Research suggests that twice-weekly testosterone cypionate injections may provide more stable hormone levels, improved comfort, fewer peaks and troughs, and potentially fewer side effects than traditional intramuscular (IM) injections. Learn how personalized dosing and injection frequency can optimize TRT outcomes and improve your overall treatment experience.

Read More
Other Chris Lyons Other Chris Lyons

NAD+ Therapy: Benefits, Science, and Who May Benefit

NAD+ therapy is gaining attention for its potential to support cellular energy, mitochondrial function, healthy aging, and overall wellness. Learn how subcutaneous NAD+ injections work, explore the latest research, understand potential benefits and side effects, and find out who may be a good candidate for this innovative therapy.

Read More
Other Chris Lyons Other Chris Lyons

The Benefits of Glutathione Injections: Supporting Your Body’s Master Antioxidant

Glutathione is often called the body's master antioxidant because it plays a critical role in protecting cells from oxidative stress, supporting liver detoxification, maintaining immune function, and promoting overall wellness. As natural glutathione levels decline with age, chronic illness, and environmental stressors, injectable glutathione may help restore optimal levels more effectively than oral supplements. In this evidence-based guide, we explore the potential benefits of subcutaneous glutathione injections, current research, safety considerations, and how personalized treatment at Affinity Whole Health can support long-term health optimization.

Read More
Other Affinity Other Affinity

Low-Dose Oral Minoxidil for Healthier Hair: What Recent Studies and Clinical Guidelines Show

Many people notice thinning hair or pattern baldness that affects confidence and self-image. At Affinity Whole Health, we understand these concerns and are pleased to offer compounded low-dose oral minoxidil as a convenient option for supporting hair regrowth in suitable patients. Recent research and clinical guidelines highlight its effectiveness for both male androgenetic alopecia and female-pattern hair loss when used appropriately.

Read More

CAG Repeats and Personalized TRT: Why We Treat the Patient, Not Just the Numbers

One powerful genetic factor that explains why two men with nearly identical testosterone levels can experience very different symptoms - and respond differently to treatment - is the CAG repeat polymorphism in the androgen receptor gene. This genetic variation underscores why we prioritize treating the patient while still rigorously respecting laboratory data for safety and optimization.

Read More
Other Affinity Other Affinity

Upcoming PCAC Meeting: What the July 2026 Review Means for Compounded Peptides

The Pharmacy Compounding Advisory Committee (PCAC) is scheduled to meet on July 23–24, 2026, at the FDA’s White Oak Campus. This public advisory committee meeting will evaluate seven peptides for potential inclusion on the FDA’s Section 503A Bulk Drug Substances List. Here’s what’s on the agenda, which peptides are under review, and what it could mean for patients and practitioners.

Read More

Testosterone Therapy for Men Under Physical Stress: When Recovery Starts With Hormones

Your job is physically demanding. You push hard every day, and you expect your body to keep up. But if you've been noticing that recovery takes longer than it used to, that your energy drops before your shift ends, or that the strength you've worked for seems harder to hold onto β€” your hormones may be playing a bigger role than you think.

Read More
Other Mason Kamlowsky Other Mason Kamlowsky

GHK-Cu and Tretinoin/Niacinamide: Powerful Individual Tools for Healthier, More Youthful Skin

At Affinity Whole Health, we focus on evidence-based options that support skin health and healthy aging. Two standout topicals we often discuss with patients are GHK-Cu (the copper-binding regenerative peptide) and tretinoin combined with niacinamide. Many patients explore using them together for complementary benefits. Here’s a clear look at what each offers individually, plus how they can work synergistically.

Read More
Weight Loss Mason Kamlowsky Weight Loss Mason Kamlowsky

Obesity Rates Are Finally Declining β€” What Epic’s Massive Dataset Reveals About GLP-1 Medications

For years, adult obesity rates in the U.S. climbed steadily. Then something changed. New data from Epic, one of the largest electronic health record systems in the country, shows that the long-term rise in obesity has reversed. This isn’t based on a small survey β€” it comes from Epic’s Cosmos dataset, representing hundreds of millions of patient records

Read More
Weight Loss Mason Kamlowsky Weight Loss Mason Kamlowsky

Retatrutide vs. Currently Available GLP-1 Medications: What the Data Shows

New data on retatrutide continues to generate excitement. As an investigational triple agonist, it has shown impressive weight-loss results in clinical trials. However, when we compare it with the currently available GLP-1 medications β€” semaglutide and tirzepatide β€” the picture becomes clearer for most patients. At Affinity Whole Health, we follow the latest research closely so we can give honest, evidence-based guidance. Here’s what the most current published studies show.

Read More
Weight Loss, Hormones Mason Kamlowsky Weight Loss, Hormones Mason Kamlowsky

GLP-1 Medications and Weight Loss: New Research Shows They Work Across Diverse Patients – With One Important Difference for Women

At Affinity Whole Health, we prescribe compounded GLP-1 receptor agonists (such as semaglutide and tirzepatide) to many patients seeking sustainable weight loss and better metabolic health. One question we often hear is: β€œDo these medications work the same for everyone?” A major new study published in JAMA Internal Medicine provides reassuring, high-quality answers.

Read More